Clinical trial
Dialysis Patients' Response to IV Iron With Elevated Ferritin
NCT00224081 is registered in ClinicalTrials.gov with Watson Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dialysis Patients' Response to IV Iron With Elevated Ferritin
- Lead sponsor
- Watson Pharmaceuticals
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2004
- Completion date
- Not reported
- Enrollment
- 134 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, iron-deficiency, hemodialysis, kidney failure, chronic